PharmaBiz.com News headlines from PharmaBiz.com https://www.pharmabiz.com/ https://www.pharmabiz.com/images/logo.jpg pharmabiz.com https://www.pharmabiz.com KSRPA demands an IPS officer as Commissioner of State Ayush dept to curb the menace of fake doctors The Karnataka State Registered Pharmacists Association (KSRPA) has demanded an administrative restructuring of the State department of Ayush, with the appointment of an IPS officer as Commissioner to curb the menace of fake doctors and protect public health. https://www.pharmabiz.com/NewsDetails.aspx?aid=187146&sid=1 Wednesday, July 15, 2026 08:00 IST Anna University academic demands recognition to B.Tech pharmacy/engg in NPC Bill A major legislative showdown is brewing over the future of technical pharmacy education in India as academic leaders formally challenge the structural framework of the upcoming National Pharmacy Commission (NPC) Bill, 2026. https://www.pharmabiz.com/NewsDetails.aspx?aid=187147&sid=1 Wednesday, July 15, 2026 08:00 IST Eyebrows are being raised over continued functioning of PCI president Dr MK Patel in administrative activities Fresh questions are being raised over the functioning of the Pharmacy Council of India (PCI) after a representation was submitted to the Union health minister JP Nadda, alleging that PCI president Dr Montu Kumar Patel continues https://www.pharmabiz.com/NewsDetails.aspx?aid=187148&sid=1 Wednesday, July 15, 2026 08:00 IST PCI asks institutions to use USP's LMS platform for exposure of students to global standards The Pharmacy Council of India (PCI) has sought all pharmacy colleges, universities and students to make use of the learning opportunities provided by the United States Pharmacopoeia (USP) through its Education Learning https://www.pharmabiz.com/NewsDetails.aspx?aid=187149&sid=1 Wednesday, July 15, 2026 08:00 IST Maha FDA cracks down on blood centres, suspends 34 licences and cancels 4 for violating drug norms In one of its most stringent enforcement drives against violations in blood transfusion services, the Maharashtra Food and Drug Administration (FDA) has taken action against 23 blood centres and 15 blood storage centres across https://www.pharmabiz.com/NewsDetails.aspx?aid=187150&sid=1 Wednesday, July 15, 2026 08:00 IST NGOs call for expedited hearing on access to breast cancer drug Ribociclib The Working Group on Access to Medicines and Treatments, a network of patient advocates and civil society organisations, has submitted a representation to the Chief Justice of the Kerala High Court requesting an https://www.pharmabiz.com/NewsDetails.aspx?aid=187118&sid=1 Tuesday, July 14, 2026 08:00 IST Indian pharma set to transition from scale─led production to precision─driven manufacturing: Anurag Kumar Indian pharmaceutical manufacturing will be defined by a transition from scale─led production to precision─driven manufacturing, alongside a stronger focus on regulated global markets and innovation─led https://www.pharmabiz.com/NewsDetails.aspx?aid=187119&sid=1 Tuesday, July 14, 2026 08:00 IST DCOIWA seeks IPCA membership and announces new Hyderabad Training Centre at Daman congress The 4th national annual general body meeting of the Drugs Control Officers (India) Welfare Association (DCOIWA), held in the Union territory of Daman on July 11, has resolved to formally request https://www.pharmabiz.com/NewsDetails.aspx?aid=187120&sid=1 Tuesday, July 14, 2026 08:00 IST IPC invites IT experts to drive digital transformation, AI integration and lab modernisation In a significant move to accelerate the digital transformation of India's pharmaceutical quality and regulatory ecosystem, the Indian Pharmacopoeia Commission (IPC) has invited applications from https://www.pharmabiz.com/NewsDetails.aspx?aid=187121&sid=1 Tuesday, July 14, 2026 08:00 IST NPPA notifies exemption of Biological E's Pneubevax 14 from DPCO pricing The National Pharmaceutical Pricing Authority (NPPA) has granted exemption to Biological E's 14─valent pneumococcal conjugate vaccine (PCV), Pneubevax 14 from pricing regulations for a period of five years. https://www.pharmabiz.com/NewsDetails.aspx?aid=187122&sid=1 Tuesday, July 14, 2026 08:00 IST India's trade curbs and PLI push to boost domestic pharma against China: Arun Patel The Indian pharmaceutical companies are profiting from the Union government's minimum import─price measures, anti─dumping action and PLI─led (production linked incentive) capacity creation which are https://www.pharmabiz.com/NewsDetails.aspx?aid=187080&sid=1 Monday, July 13, 2026 08:00 IST FPME invites experts to develop ICP and IVP frameworks for merchant exporters The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has invited experienced Subject Matter Experts (SMEs) from the pharmaceutical export industry to contribute to the development https://www.pharmabiz.com/NewsDetails.aspx?aid=187081&sid=1 Monday, July 13, 2026 08:00 IST DCC recommends amendment of rules to mandate registration of blood centres in e─Raktkosh portal The Drugs Consultative Committee (DCC) and the Drugs Technical Advisory Board (DTAB) have recommended to amend the Drugs and Cosmetics Rules, 1945 to mandate registration of blood centres on the https://www.pharmabiz.com/NewsDetails.aspx?aid=187082&sid=1 Monday, July 13, 2026 08:00 IST Trade experts recommend stronger packaging standards to boost export competitiveness Trade experts have identified a set of actionable measures to strengthen packaging standards and improve the global competitiveness of Indian exports. The recommendations focus on enhancing packaging quality, https://www.pharmabiz.com/NewsDetails.aspx?aid=187083&sid=1 Monday, July 13, 2026 08:00 IST DCC asks SLAs to update cancellation or suspension of license online The Drugs Consultative Committee (DCC) and the Drugs Technical Advisory Board (DTAB) of the Union health ministry has recommended to the State Licensing Authorities (SLAs) to submit details of cancellation https://www.pharmabiz.com/NewsDetails.aspx?aid=187084&sid=1 Monday, July 13, 2026 08:00 IST Indian pharmaceutical market eyes strong double─digit growth by December The Indian Pharmaceutical Market is on track to record a highly encouraging double─digit value growth of 11.3 per cent for the full year ending December 2026, according to the latest market data released by https://www.pharmabiz.com/NewsDetails.aspx?aid=187075&sid=1 Saturday, July 11, 2026 08:00 IST Pharmacy colleges emphasise on multifaceted training as career horizons expand Pharmacy colleges in the country are emphasising on multifaceted training to its students as it equips the students for the expanding roles in research and innovation across allied sectors of medical underwriting, https://www.pharmabiz.com/NewsDetails.aspx?aid=187076&sid=1 Saturday, July 11, 2026 08:00 IST Dadhichi College in Odisha to organize GRPP training program to elevate community pharmacy standards With community pharmacies increasingly serving as the vital first point of contact in the healthcare ecosystem, Dadhichi College of Pharmacy in Cuttack is set to organize a prestigious state─level training programme on https://www.pharmabiz.com/NewsDetails.aspx?aid=187077&sid=1 Saturday, July 11, 2026 08:00 IST Pharma companies are expanding the use of predictive analytics across the value chain: Expert Pharmaceutical companies are expanding the use of predictive analytics across the value chain. In research and development, artificial intelligence (AI) helps identify suitable patient cohorts for clinical trials, improving https://www.pharmabiz.com/NewsDetails.aspx?aid=187078&sid=1 Saturday, July 11, 2026 08:00 IST NPPA fixes retail price of 39 new drugs based on 47 applications The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of 39 new drugs in applications filed by 47 applicants under the provisions of the Drugs Prices Control Order (DPCO), 2013, including https://www.pharmabiz.com/NewsDetails.aspx?aid=187079&sid=1 Saturday, July 11, 2026 08:00 IST Draft NPC Bill 2026 faces sharp criticism over bureaucratic overreach and exclusion of practicing pharmacists The draft National Pharmacy Commission (NPC) Bill, 2026, faces significant criticism regarding its structural composition, with experts warning that it heavily favours bureaucratic and academic representation at the expense of practicing professionals. https://www.pharmabiz.com/NewsDetails.aspx?aid=187048&sid=1 Friday, July 10, 2026 08:00 IST Commerce ministry initiates India, Taiwan collaboration on APIs through strategic partnership The Union commerce ministry, Department of Commerce (DoC), has initiated a fresh effort to strengthen pharmaceutical cooperation between India and Taiwan by sharing a list of active pharmaceutical ingredients (APIs) identified https://www.pharmabiz.com/NewsDetails.aspx?aid=187049&sid=1 Friday, July 10, 2026 08:00 IST FCDK urges govt to restrict licenses for pharmacies & private hospitals on lines of liquor & fertiliser shops The Federation of Chemists and Druggists of Karnataka (FCDK) has urged the state government to restrict and suspend new licenses for medical stores and private hospitals, in alignment with fertilizer, pesticide, and liquor retail shops. https://www.pharmabiz.com/NewsDetails.aspx?aid=187050&sid=1 Friday, July 10, 2026 08:00 IST DCC recommends setting up a sub─committee for regulation of printed pharma packaging materials industry The drug authorities are examining a proposal to bring in a regulatory framework for manufacturers and suppliers of printed pharmaceutical packaging materials in order to curb illicit diversion and misuse of these products in spurious and counterfeit drugs circulation. https://www.pharmabiz.com/NewsDetails.aspx?aid=187051&sid=1 Friday, July 10, 2026 08:00 IST Merchant exporters raise several regulatory & procedural issues that are affecting pharma exports The Federation of Pharmaceutical and Allied Products Merchant Exporters (FPME) has highlighted several regulatory and procedural issues that are affecting pharmaceutical exports from India. https://www.pharmabiz.com/NewsDetails.aspx?aid=187052&sid=1 Friday, July 10, 2026 08:00 IST NPPA clarifies 'worked out price' will be notified as retail price for new drugs The National Pharmaceutical Pricing Authority (NPPA) has clarified that the 'worked out price' of a new drug for existing manufacturers of scheduled formulations will be notified as retail price applicable to the applicant company https://www.pharmabiz.com/NewsDetails.aspx?aid=187053&sid=1 Friday, July 10, 2026 08:00 IST Clinical and research─led dental education gives a fillip to patient care: Prof. Puneet Ahuja Clinical excellence and research can no longer exist in isolation. The future of dental education lies in creating professionals who are equally adept at delivering patient care, interpreting scientific evidence, and https://www.pharmabiz.com/NewsDetails.aspx?aid=187019&sid=1 Thursday, July 9, 2026 08:00 IST Exporters raise concern over customs' conversion of drawback shipping bills into free shipping bills Pharma exporters have raised serious concerns over the alleged practice by customs authorities of converting drawback shipping bills into free shipping bills in cases where the declared Free on Board (FOB)/Cost, https://www.pharmabiz.com/NewsDetails.aspx?aid=187020&sid=1 Thursday, July 9, 2026 08:00 IST Haryana FDA launches investigation into potential patient safety risks over 'Aciloc' branding The Food and Drugs Administration (FDA) of Haryana has launched an investigation into potential patient safety risks linked to the branding of "Aciloc," a widely recognized pharmaceutical product. https://www.pharmabiz.com/NewsDetails.aspx?aid=187021&sid=1 Thursday, July 9, 2026 08:00 IST BSE Healthcare index up by 12.7% in first half ended June 2026, BSE Sensex declines by 10.2% The BSE Healthcare index of 126 companies moved up by 12.7 per cent during the first half ended June 2026 as against broad based BSE Sensex index of 30 companies which declined by 10.2 per cent. https://www.pharmabiz.com/NewsDetails.aspx?aid=187022&sid=1 Thursday, July 9, 2026 08:00 IST